Cargando…

Potential Value of Cetylmannoside‐modified Liposomes as Carriers of Macrophage Activators to Human Blood Monocytes

The present study was undertaken to examine the potential value of cetylmannoside‐modified multilamellar liposomes (Man‐MLV) as carriers for transfer of macrophage activators to blood monocytes. Highly purified blood monocytes were isolated by centrifugal elutriation from healthy donors under cndoto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamashita, Chikamasa, Sone, Saburo, Ogura, Takeshi, Kiwada, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1991
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918470/ https://www.ncbi.nlm.nih.gov/pubmed/1905703 http://dx.doi.org/10.1111/j.1349-7006.1991.tb01888.x

Ejemplares similares

Suppression by Interleukin 4 of Activation of Human Blood Monocytes to the Tumoricidal State
por: Nishioka, Yasuhiko, et al.
Publicado: (1990)

Killing of Alveolar Macrophages and of Monocytes that Have Responded to Granulocyte‐Macrophage Colony‐stimulating Factor by Human Lymphokine‐activated Killer Cells
por: Sone, Saburo, et al.
Publicado: (1989)

Human Alveolar Macrophages Augment Natural Killer Cell Stimulatory Factor (Interleukin‐12)‐inducible Killer Activity from Autologous Blood Lymphocytes
por: Haku, Takashi, et al.
Publicado: (1995)

Production of Tumor Necrosis Factor‐α by Alveolar Macrophages of Lung Cancer Patients
por: Okubo, Akio, et al.
Publicado: (1990)

Cyclosporin A Enhances Susceptibility of Multi‐drug Resistant Human Cancer Cells to Anti‐P‐glycoprotein Antibody‐dependent Cytotoxicity of Monocytes, but Not of Lymphocytes
por: Yano, Seiji, et al.
Publicado: (1994)

Enhancement by Monocytes of Perform Production and Its Gene Expression by Human CD8+ T Cells Stimulated with Interleukin‐2
por: Sugihara, Kohji, et al.
Publicado: (1992)

Interleukin‐2‐inducible Killer Activity and Its Regulation by Blood Monocytes from Autologous Lymphocytes of Lung Cancer Patients
por: Sone, Saburo, et al.
Publicado: (1991)

Targeted Liposomal Drug Delivery to Monocytes and Macrophages
por: Kelly, Ciara, et al.
Publicado: (2011)

Induction Mechanism of Human Blood CD8(+) T Cell Proliferation and Cytotoxicity by Natural Killer Cell Stimulatory Factor (Interleukin‐12)
por: Nabioullin, Roustem, et al.
Publicado: (1994)

Lymphokine‐activated Killer Induction and Its Regulation by Macrophages in Malignant Pleural Effusions
por: Yanagawa, Hiroaki, et al.
Publicado: (1989)

Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats
por: Ichihara, Masako, et al.
Publicado: (2010)

Granulocyte‐Macrophage Colony‐stimulating Factor Augments Lymphokine‐activated Killer Activity from Pleural Cavity Mononuclear Cells of Lung Cancer Patients without Malignant Effusion
por: Takahashi, Keiji, et al.
Publicado: (1995)

Investigation of Fatty Acid Ketohydrazone Modified Liposome's Properties as a Drug Carrier
por: Hayashi, Keita, et al.
Publicado: (2015)

Inhibition by Fibrin Coagulation of Lung Cancer Cell Destruction by Human Interleukin‐2‐activated Killer Cells
por: Atagi, Shinji, et al.
Publicado: (1992)

Enhancement of Therapeutic Effect of Interleukin‐2 on Spontaneous Pulmonary Metastases of Lewis Lung Carcinoma by Killer Helper Factor Associated with Increased Induction of Killer Activity
por: Fukuta, Katsuyuki, et al.
Publicado: (1989)

Autonomous Expressions of Cytokine Genes by Human Lung Cancer Cells and Their Paracrine Regulation
por: Mizuno, Kazuto, et al.
Publicado: (1994)

Monoclonal Anti‐P‐glycoprotein Antibody‐dependent Killing of Multidrug‐resistant Tumor Cells by Human Mononuclear Cells
por: Heike, Yuji, et al.
Publicado: (1990)

Anti‐ganglioside GM(2) Monoclonal Antibody‐dependent Killing of Human Lung Cancer Cells by Lymphocytes and Monocytes
por: Hanibuchi, Masaki, et al.
Publicado: (1996)

Efficiency of pH-Sensitive Fusogenic Polymer-Modified Liposomes as a Vaccine Carrier
por: Watarai, Shinobu, et al.
Publicado: (2013)

Lipopolysaccharide-induced inflammation in monocytes/macrophages is blocked by liposomal delivery of G(i)-protein inhibitor
por: Tucureanu, Monica Madalina, et al.
Publicado: (2017)

Effector Cell Analysis of Human Multidrug‐resistant Cell Killing by Mouse‐Human Chimeric Antibody against P‐Glycoprotein
por: Nishioka, Yasuhiko, et al.
Publicado: (1992)

Development of Novel Radiogallium-Labeled Bone Imaging Agents Using Oligo-Aspartic Acid Peptides as Carriers
por: Ogawa, Kazuma, et al.
Publicado: (2013)

Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
por: Jensen, Simon S, et al.
Publicado: (2013)

Monocytes and macrophages in malignant melanoma. I. Peripheral blood macrophage precursors.
por: Currie, G. A., et al.
Publicado: (1977)

Ontogeny and Polarization of Macrophages in Inflammation: Blood Monocytes Versus Tissue Macrophages
por: Dey, Adwitia, et al.
Publicado: (2015)

Liposome-Based Carriers for CRISPR Genome Editing
por: Yin, Xing, et al.
Publicado: (2023)

Application of apolipoprotein E-modified liposomal nanoparticles as a carrier for delivering DNA and nucleic acid in the brain
por: Tamaru, Mina, et al.
Publicado: (2014)

Monocytes and macrophages in malignant melanoma. III. Reduction of nitroblue tetrazolium by peripheral blood monocytes.
por: Hedley, D. W., et al.
Publicado: (1978)

Oral contraceptives modify DNA methylation and monocyte-derived macrophage function
por: Campesi, Ilaria, et al.
Publicado: (2012)

Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia
por: Fiorcari, Stefania, et al.
Publicado: (2016)

Red Blood Cell Substitutes: Liposome Encapsulated Hemoglobin and Magnetite Nanoparticle Conjugates as Oxygen Carriers
por: Hafeez, Saleha, et al.
Publicado: (2023)

Liposome-coated lipoplex–based carrier for antisense oligonucleotides
por: Wyrozumska, Paulina, et al.
Publicado: (2014)

Characterization of liposomal carriers for the trans-scleral transport of Ranibizumab
por: Joseph, Rini Rachel, et al.
Publicado: (2017)

Liposomes as Multifunctional Nano-Carriers for Medicinal Natural Products
por: Cheng, Xiamin, et al.
Publicado: (2022)

Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases()
por: Pandian, Sureshbabu Ram Kumar, et al.
Publicado: (2022)

DNA–Liposome Hybrid Carriers for Triggered Cargo Release
por: Baumann, Kevin N., et al.
Publicado: (2022)

Design and applications of liposome-in-gel as carriers for cancer therapy
por: Mou, Yixuan, et al.
Publicado: (2022)

Liposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Application
por: Dymek, Michał, et al.
Publicado: (2023)

Transient effects of empty liposomes on hepatic macrophage populations in rats
por: Pervin, Munmun, et al.
Publicado: (2016)

mRNA Transfection-Induced Activation of Primary Human Monocytes and Macrophages: Dependence on Carrier System and Nucleotide Modification
por: Moradian, Hanieh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4uv2263ajbng6eqksb04pik3qf